Morgan Stanley’s Pharming Group PHAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Hold |
2,900
| – | – | ﹤0.01% | 6509 |
|
|
2025
Q1 | $24.3K | Buy |
2,900
+300
| +12% | +$2.51K | ﹤0.01% | 6502 |
|
|
2024
Q4 | $26.2K | Sell |
2,600
-700
| -21% | -$7.05K | ﹤0.01% | 6493 |
|
|
2024
Q3 | $27.2K | Buy |
3,300
+500
| +18% | +$4.13K | ﹤0.01% | 6403 |
|
|
2024
Q2 | $23.4K | Hold |
2,800
| – | – | ﹤0.01% | 6408 |
|
|
2024
Q1 | $29.4K | Sell |
2,800
-2,800
| -50% | -$29.4K | ﹤0.01% | 6376 |
|
|
2023
Q4 | $64K | Buy |
5,600
+3,100
| +124% | +$35.4K | ﹤0.01% | 6307 |
|
|
2023
Q3 | $28.5K | Hold |
2,500
| – | – | ﹤0.01% | 6371 |
|
|
2023
Q2 | $29.1K | Hold |
2,500
| – | – | ﹤0.01% | 6426 |
|
|
2023
Q1 | $33.8K | Sell |
2,500
-4,149
| -62% | -$56K | ﹤0.01% | 6426 |
|
|
2022
Q4 | $73.3K | Sell |
6,649
-101
| -1% | -$1.11K | ﹤0.01% | 6117 |
|
|
2022
Q3 | $66K | Buy |
6,750
+4,250
| +170% | +$41.6K | ﹤0.01% | 6277 |
|
|
2022
Q2 | $22K | Hold |
2,500
| – | – | ﹤0.01% | 6938 |
|
|
2022
Q1 | $22K | Hold |
2,500
| – | – | ﹤0.01% | 7109 |
|
|
2021
Q4 | $22K | Sell |
2,500
-48
| -2% | -$422 | ﹤0.01% | 7186 |
|
|
2021
Q3 | $24K | Hold |
2,548
| – | – | ﹤0.01% | 7035 |
|
|
2021
Q2 | $29K | Buy |
2,548
+2,500
| +5,208% | +$28.5K | ﹤0.01% | 6875 |
|
|
2021
Q1 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 7366 |
|